GE Healthcare Omnipaque Iohexol Injection Recall Expanded for Particulate Matter in 306,810 Vials (D
GE Healthcare recalled Omnipaque iohexol injection after discovery of particulate matter. The recall covers 306,810 vials distributed nationwide in the United States. WHS: Distributed by GE Healthcare Inc., Marlborough, MA. Consumers should stop use and consult a healthcare provider for guidance.


